Gilead Sciences

As we discuss the possibility of emerging into business intelligence software we must keep in mind the overall purpose of using any type of software is to reach strategic goals in order to increase market shares. I will discuss how business intelligence software will allow us to meet those strategic goals. We will establish what type of information and analysis capabilities will be available once this business intelligence software is implemented. We will discuss hardware and system software that will be required to run specific business intelligence software. Lastly, I will give a brief synopsis on three vendors (IBM, Microsoft Microsoft and Oracle) that are dominating the business information software

Pharmacy benefit managers (PBMs) are companies that administer drug benefit programs for employers and health insurance carriers. PBMs contract with managed care organizations, self-insured employers, insurance companies, unions, Medicaid and Medicare managed care plans, the Federal Employees Health Benefits Program and other federal, state, and local government entities to provide managed prescription drug benefits.

“If opportunity doesn’t knock, build a door.” I learned this saying and followed it on December 4th when I decided to invest in some stock shares. I want to go to college and so far I haven’t gotten any letters or offers from any colleges. So I figured that I would have to find a way to earn around $100,000 over the course of the next 4 years. In order to make it easier on myself I decided that I should make around $25,000 a year. My original strategy was to watch what companies are performing well or seem like they will be successful.

Bristol-Myers Squibb Company is the outcome of the merging of Bristol-Myers and Squibb Corporation in 1989. Bristol-Myers Squibb is one of the world’s largest pharmaceutical companies head quartered in New York. BMS has global research facilities and manufacturing plants mainly in the United States and Europe (Hoovers, 2015). The corporation has a unique set of strategic principles that help built the company. The company divested in the nutritional and pharmaceutical divisions. BMS expanded its strategies to become a biopharmaceutical leader. According to Hoovers (2015), the company engaged in the String-of- Pearls pharmaceutical strategy that added barriers to imitate biotech drugs and products within the company’s pipeline. This company demonstrates functional-level strategies that focuses on innovation and technology. BMS, the multi-business has undergone issues associated with ethics, research, marketing and quality manufacturing. Therefore, BMS strategies offers insight on the company struggles and operations.

Eli Lilly’s main focal points are quality, innovation, and customer care. With a focus on the not yet met medical needs of clients, the response time in which they deliver important drug therapies hit the market, and top

What has been the financial performance of AstraZeneca over the last three years, and how does this compare to a company in the same industry?

The Christian ties do not cease with the titles and ranks of those within Gilead, but instead seep into every societal existence. All of the stores have biblical names: Loaves and Fishes, All Flesh, Milk and Honey. Even the automobiles have biblical names like Behemoth, Whirlwind, and Chariot. Utilizing religious terminology as descriptors of people, ranks, and businesses, Atwood illustrates the cover-up of political chicanery through reverent language. It provides an omniscient reminder that Gilead’s founders consistently act on the authority of the Bible itself and root all aspects of the Republic deep within Christianity. Politics and religion sleep in the same bed in Gilead making their slogan “God is a National Resource” a clarion call.

Based in the United Kingdom, GW Pharmaceuticals was co-founded by Dr. Brian Whittle and Dr. Geoffrey Guy in 1988 (GW Pharmaceuticals, 2014) with the focuses of “discovering, developing and commercializing” medications which harness the therapeutic effects cannabis components for use in areas of oncology and Central Nervous System Disorders (GW Pharmaceuticals, 2014). GW’s lead product, Satives®, was the “world’s first plant derived cannabinoid prescription drug” with its main use being for the treatment of MS spasticity (GW Pharmaceuticals, 2014). The company is also developing Epidiolex® for the use of controlling pediatric epilepsy as well as researching many other avenues for product development (GW Pharmaceuticals, 2014). Since the initial public offering in 2013 on the NASDAQ Global Market, GW has rapidly grown and now the company “occupies a world leading position in cannabinoid science” (GW Pharmaceuticals, 2014). With patients as the driving force behind their efforts,

Twila Day left the meeting excited, but also a little nervous. Her Technology and Applications Group had just been given approval by the Director’s Council of SYSCO to proceed with a company- wide deployment of business intelligence (BI) software. The effort was intended to help SYSCO, the largest food distributor in North America, make better use of the information generated by its operations and serve its customers better. The Director’s Council, a group of senior managers with substantial power and influence, had been impressed enough by the results of a

Gilead faces significant competition from other large biotech and pharmaceutical companies. Many of these competing companies have vastly greater financial resources than Gilead. Most of these competitors also have more product offerings and have existed longer in the markets in which Gilead competes. Gilead’s HIV products primarily compete with products from a joint venture established between GlaxoSmithKline Inc. (GSK) and Pfizer Inc. (Pfizer). Gilead also competes with products marketed by AbbVie Inc. (AbbVie). In addition, a new product launched in the fourth quarter of 2013 by ViiV Healthcare (ViiV), could adversely impact sales of Gilead HIV products.

As technology advances, advances in the pharmaceutical industry increase as well. While most companies use the mentality of screening drugs that show the most binding affinity or particularity of drug applicants to a single defined target, this is not always the best way of doing things. Many off target activities or multi-targeted particularities have been successful in targeted therapeutics. For example, Imatinib marketed by Novartis and Sorafenib co-developed and co-marketed by Bayer and Onyx Pharmaceuticals and Nexavar have shown that looking at the broader spectrum of biological context of how a specific agent works is very important. Increasing importance of translational and clinical research in the early stages of drug development can help connect the drug’s activity to biological impact and clinical significance.

In 2005, Phillip (Phil) Landgraf faced several glaring problems in the financial performance of his company, BioPharma, Inc. The firm had experienced a steep decline in profits and very high costs at its plants in Germany and Japan. Landgraf, the company 's president for worldwide operations, knew that demand for the company 's products was stable across the globe. As a result, the surplus capacity in his global production network looked like a luxury he could no longer afford.

R.L Fielding (2008) reiterates that Business Intelligence is a thorough and holistic analysis of the company records, data, information, and software application for effective decision making. All decision making processes need an organized, readily-accessible, and human readable compilations of data. With the use of an effective tool the firm can easily figure out their own business processes, the behavior of their customers, and the economic trend of the industry. With these facts, the firm can arrive at a better strategy to achieve their specified goals with confidence.

These are original texts and were written and revised on 10 February 2012 by Gartner Inc. The original document is part of Gartner 's Magic Quadrant research methodology to provide a graphical and analytical competitive positioning of Business Intelligence technology providers.

B2B is the commercial transactions between enterprises and enterprises through electronic media such as the Internet Extranet. B2B E-Commerce is the arising from suppliers to customers who want to reduce the cost and length of procurement as well as international organizations to improve the efficiency and security of communication over the network even more.